ChartMill assigns a Buy % Consensus number of 82% to COLL. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-07 | Truist Securities | Maintains | Buy -> Buy |
| 2025-11-07 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-10-28 | Needham | Reiterate | Buy -> Buy |
| 2025-05-09 | Piper Sandler | Reiterate | Neutral -> Neutral |
| 2025-04-09 | Needham | Reiterate | Buy -> Buy |
| 2025-03-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-04 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-01-10 | Needham | Upgrade | Hold -> Buy |
| 2025-01-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-11 | Piper Sandler | Reiterate | Neutral -> Neutral |
| 2024-09-05 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-08-09 | Needham | Reiterate | Hold |
| 2024-08-09 | Truist Securities | Maintains | Buy -> Buy |
| 2024-08-09 | Piper Sandler | Reiterate | Neutral -> Neutral |
| 2024-07-30 | Needham | Reiterate | Hold |
| 2024-07-30 | HC Wainwright & Co. | Upgrade | Neutral -> Buy |
| 2024-06-07 | Jefferies | Upgrade | Hold -> Buy |
| 2024-05-10 | Needham | Downgrade | Buy -> Hold |
| 2024-05-10 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2024-04-11 | Needham | Reiterate | Buy -> Buy |
| 2024-02-26 | Truist Securities | Maintains | Buy -> Buy |
| 2024-02-23 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2024-02-02 | Needham | Reiterate | Buy -> Buy |
| 2024-01-04 | Needham | Maintains | Buy -> Buy |
| 2024-01-04 | Truist Securities | Maintains | Buy -> Buy |
| 2024-01-04 | Jefferies | Downgrade | Buy -> Hold |
| 2023-08-25 | Needham | Maintains | Buy -> Buy |
| 2023-08-04 | Needham | Reiterate | Buy -> Buy |
| 2023-08-04 | HC Wainwright & Co. | Reiterate | Neutral |
| 2023-05-30 | Needham | Reiterate | Buy -> Buy |
11 analysts have analysed COLL and the average price target is 47.74 USD. This implies a price increase of 3.26% is expected in the next year compared to the current price of 46.23.
The consensus rating for COLLEGIUM PHARMACEUTICAL INC (COLL) is 81.8182 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering COLLEGIUM PHARMACEUTICAL INC (COLL) is 11.